Suchergebnisse - (Subject:"Adalimumab")

PubPharm (12.467)

141

Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2024

von Woo, H. | Shin, G. | Lee, D. | +2

ErratumIn: BioDrugs. 2024 Jan 22;:. - PMID 38252342

142

Adalimumab Persistence and Its Biosimilar in Inflammatory Bowel Disease : A Real-World Study

enthalten in: Journal of clinical medicine | 2024

von Fernández-Cano, M. | Fernández-Cano, A. | Martín-Rodríguez, M. | +3

143

Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents : data from the ENEIDA registry

enthalten in: Therapeutic advances in gastroenterology | 2024

von Calafat, M. | Torres, P. | Tosca-Cuquerella, J. | +56

144

Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network

enthalten in: Scientific reports | 2024

von Larid, G. | Baudens, G. | Tiemdjo-Djimaffo, G. | +10

145

Ex vivo comparative immunogenicity assessment (EVCIA) to determine relative immunogenicity in chronic plaque psoriasis in participants receiving Humira® or undergoing repeated switches between Humira® and AVT02

enthalten in: Immunotherapy advances | 2024

von Richter, K. | Haliduola, H. | Schockaert, J. | +4

146

Persistent Constitutional Symptoms and Cholestasis During Anti-TNF Therapy as a Harbinger of a Surprising Condition

enthalten in: Gastroenterology | 2024

von Fonseca Chebli, J. | Akkari Evangelista, R. | Chebli, L.

147

'Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients'-response to Yu et al

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Mastorino, L. | Ortoncelli, M. | Dapavo, P. | +2

148

Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece

enthalten in: Clinical drug investigation | 2024

von Gourzoulidis, G. | Solakidi, A. | Psarra, M. | +2

149

Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab : A 52-Week Real-Life Study

enthalten in: Clinical, cosmetic and investigational dermatology | 2024

von Martora, F. | Marasca, C. | Cacciapuoti, S. | +5

150

Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis : A Belgian Multicenter Cohort Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Lemmens, P. | Louis, E. | Van Moerkercke, W. | +19